The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Utilize tax strategies to maximize your investment returns. Discover how to enhance your financial outcomes through effective tax planning.
19,852 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Nearly one-third of IRA rollovers sit in cash for seven years, draining retirement potential. Vanguard data shows man...
As AI data centers ramp up, two independent power producers headline the market: Constellation Energy and Vistra. Thi...
A glamorous Monaco moment shows more than style—it reveals how celebrity influence can impact your money choices. Lea...
A new study shows that choosing to retire at 62 can shave roughly $250,000 from lifetime income, while rising cogniti...
Value stocks are resurging as inflation cools and markets favor durable cash flow. This piece examines why Vanguard M...
A practical comparison of Corning and QuantumScape for 2026. Learn where each stock shines, the risks you should watc...
McDonald’s brings back its fried apple pie for America’s semiquincentennial, a limited-time move that fuses nostalgia...
When top investors recalibrate, markets watch closely. This piece unpacks why the billionaire Griffin sold Amazon and...
NRG Energy announced a transformative deal that doubles its generation capacity to roughly 25 GW and targets 14% annu...
In 2026, several of Vanguard's sector ETFs are outperforming the S&P 500. This guide explains why, highlights a March...
A new income model uses a $560,000 portfolio built from covered-call ETFs, preferred shares, and BDCS to generate abo...